HJ Science Statistics
Total Valuation
HJ Science has a market cap or net worth of HKD 2.47 billion. The enterprise value is 2.07 billion.
| Market Cap | 2.47B |
| Enterprise Value | 2.07B |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
HJ Science has 73.60 million shares outstanding.
| Current Share Class | 73.60M |
| Shares Outstanding | 73.60M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 16.88% |
| Owned by Institutions (%) | 8.78% |
| Float | 29.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 170.03 |
| PB Ratio | 6.61 |
| P/TBV Ratio | 6.61 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 142.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.20 |
| Quick Ratio | 4.03 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.14 |
| Interest Coverage | -972.08 |
Financial Efficiency
Return on equity (ROE) is -37.92% and return on invested capital (ROIC) is -21.55%.
| Return on Equity (ROE) | -37.92% |
| Return on Assets (ROA) | -18.17% |
| Return on Invested Capital (ROIC) | -21.55% |
| Return on Capital Employed (ROCE) | -37.26% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.03 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HJ Science has paid 4,451 in taxes.
| Income Tax | 4,451 |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | n/a |
| Average Volume (20 Days) | 1,322,182 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HJ Science had revenue of HKD 14.54 million and -150.32 million in losses. Loss per share was -2.54.
| Revenue | 14.54M |
| Gross Profit | 14.54M |
| Operating Income | -139.55M |
| Pretax Income | -150.32M |
| Net Income | -150.32M |
| EBITDA | -137.39M |
| EBIT | -139.55M |
| Loss Per Share | -2.54 |
Balance Sheet
The company has 418.30 million in cash and 14.07 million in debt, with a net cash position of 404.22 million or 5.49 per share.
| Cash & Cash Equivalents | 418.30M |
| Total Debt | 14.07M |
| Net Cash | 404.22M |
| Net Cash Per Share | 5.49 |
| Equity (Book Value) | 374.13M |
| Book Value Per Share | 6.24 |
| Working Capital | 342.18M |
Cash Flow
In the last 12 months, operating cash flow was -99.52 million and capital expenditures -1.68 million, giving a free cash flow of -101.21 million.
| Operating Cash Flow | -99.52M |
| Capital Expenditures | -1.68M |
| Depreciation & Amortization | 2.24M |
| Net Borrowing | 11.09M |
| Free Cash Flow | -101.21M |
| FCF Per Share | -1.38 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -959.44% |
| Pretax Margin | -1,033.51% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HJ Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -6.08% |
| FCF Yield | -4.09% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HJ Science has an Altman Z-Score of -0.62 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.62 |
| Piotroski F-Score | 1 |